Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Orange Book Patents
Across 1 drug with upcoming expirations
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Ecoza — SPECTAZOLE
Application NDA018751 (NDA)
Ecoza — SPECTAZOLE
Application NDA018751 (NDA)
Fluocinonide — LIDEX
Application NDA016909 (NDA)
Fluocinonide — FLUOCINONIDE
Application NDA017373 (NDA)
Fluocinonide — LIDEX
Application NDA016908 (NDA)
Normodyne — NORMODYNE
Application NDA018686 (NDA)
Fluocinonide — FLUOCINONIDE
Application NDA019117 (NDA)
Fluocinonide — LIDEX
Application NDA018849 (NDA)
Normodyne — TRANDATE
Application NDA019425 (NDA)
Normodyne — TRANDATE
Application NDA018716 (NDA)
Normodyne — NORMODYNE
Application NDA018687 (NDA)
Tambocor — TAMBOCOR
Application NDA018830 (NDA)
Fluocinonide — VANOS
Application NDA021758 (NDA)
Ecoza — ECOZA
Application NDA205175 (NDA)
Ecoza — ECOZA
Application NDA205175 (NDA)
Ecoza — VIVJOA
Application NDA215888 (NDA)
Normodyne — LABETALOL HYDROCHLORIDE
Application NDA213330 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)